intellectual property


NAFTA’S Chapter 19 a potential big issue
Canada and Mexico should push very hard to preserve Chapter 19 of the original NAFTA agreement, which created a mechanism to resolve disputes over anti-dumping and countervailing duty measures, a former Mexican official said.
MSF response on the India-EFTA free trade agreement negotiations in Liechtenstein this week
Through this deal, Swiss pharmaceutical corporations are working to erode India’s ability to produce and supply generic medicines for people across the developing world.
Avoid changing TPP-related laws that damage the health of Malaysians
The Consumers’ Association of Penang calls on the Malaysian government not to make changes to the law relating to intellectual property rights to comply with the Trans-Pacific Partnership Agreement.
US to ask Argentina to expedite approval for patenting of seeds
The opening of the US market to Argentine beef exports and its continued openness to biodiesel from this country will be made conditional on a demand that Argentina change its legislation to expedite the approval of patents on seeds waiting in the pipeline.
Reject RCEP and reject unjust trade deals
Trade Justice Pilipinas expresses its opposition to the Regional Comprehensive Economic Partnership agreement or RCEP
MSF response on RCEP negotiations in the Philippines
Negotiators must protect public health safeguards that enable developing countries like India to keep supplying life-saving affordable medicines for millions of people worldwide.
TRIPS flexibilities under threat from investment disputes: a closer look at Canada’s “win” against Eli Lilly
Although Canada won in a unanimous decision, the ruling does not, however, guarantee domestic discretion going forward, contrary to the suggestion of some.
The expanding universe of IP
Granting data exclusivity for clinical trials would undermine access to medicines.
CETA bringing changes to pharma patents in Canada
A certificate of supplemental protection provides up to two years of additional protection after expiry of a patent.
Treating intellectual property as an investment, and subjecting it to treaty arbitration, can have undesirable impact
Free trade agreements tend to treat intellectual property as an investment made by investor corporations, allowing private investment disputes to be raised against the host country.